Read + Share
Gitelman SE, Simmons K, Sherr JL, Leichter SB, et al. Safety and pharmacokinetics of teplizumab in children less than 8 years of age
with stage 2 type 1 diabetes. Diabetologia 2025 Nov 6. doi: 10.1007/s00125-025-06586.
PMID: 41196293
|
 |
|
Gitelman SE, Simmons K, Sherr JL, Leichter SB, et al. Safety and pharmacokinetics of teplizumab in children less than 8 years of age
with stage 2 type 1 diabetes. Diabetologia 2025 Nov 6. doi: 10.1007/s00125-025-06586.
PMID: 41196293
|
|
|
|